Harvey I Pass Selected Research

Proteasome Endopeptidase Complex (Proteasome)

1/2012	Withaferin A inhibits the proteasome activity in mesothelioma in vitro and in vivo.
8/2010	Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harvey I Pass Research Topics

Disease

115	Neoplasms (Cancer) 11/2023 - 02/2002
74	Malignant Mesothelioma 01/2023 - 02/2002
59	Mesothelioma 01/2023 - 02/2002
36	Lung Neoplasms (Lung Cancer) 11/2023 - 06/2003
19	Carcinogenesis 09/2023 - 12/2004
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 06/2003
14	Inflammation (Inflammations) 01/2023 - 07/2010
11	Adenocarcinoma of Lung 11/2023 - 01/2006
9	Neoplasm Metastasis (Metastasis) 11/2019 - 02/2002
7	Breast Neoplasms (Breast Cancer) 10/2018 - 06/2003
6	Pleural Effusion (Pleural Effusions) 01/2022 - 01/2008
6	Adenocarcinoma 01/2021 - 02/2005
5	Infections 01/2021 - 02/2002
2	Hypoxia (Hypoxemia) 01/2023 - 01/2021
2	Hyperplasia 01/2023 - 01/2021
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2018 - 01/2018
2	Malignant Pleural Effusion 01/2018 - 01/2016
2	Wilms Tumor (Wilm's Tumor) 01/2017 - 09/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2016 - 01/2006
2	Carcinoma (Carcinomatosis) 09/2016 - 09/2013
2	Melanoma (Melanoma, Malignant) 12/2015 - 10/2012
2	Fibrosis (Cirrhosis) 08/2013 - 10/2005
2	Virus Diseases (Viral Diseases) 01/2012 - 01/2011
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2012 - 07/2006
2	Wounds and Injuries (Trauma) 05/2009 - 03/2003
2	Lung Diseases (Lung Disease) 10/2005 - 02/2002

Drug/Important Bio-Agent (IBA)

62	AsbestosIBA 01/2023 - 02/2002
40	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2007
26	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2003
13	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 02/2002
12	HMGB1 Protein (HMG1)IBA 01/2023 - 07/2010
11	CytokinesIBA 04/2023 - 02/2005
9	EnzymesIBA 11/2019 - 10/2005
8	MicroRNAs (MicroRNA)IBA 12/2019 - 03/2010
8	ImmunosorbentsIBA 10/2018 - 10/2005
8	Messenger RNA (mRNA)IBA 01/2018 - 06/2003
8	OsteopontinIBA 01/2016 - 10/2005
7	erioniteIBA 06/2017 - 01/2007
6	Protein Isoforms (Isoforms)IBA 01/2020 - 12/2008
6	Cisplatin (Platino)FDA LinkGeneric 08/2016 - 04/2004
5	Crocidolite Asbestos (Blue Asbestos)IBA 01/2016 - 04/2005
5	MesothelinIBA 01/2016 - 04/2007
4	Mineral Fibers (Mineral Fiber)IBA 09/2021 - 12/2014
4	1-methyl-1-piperidinomethane sulfonateIBA 11/2015 - 02/2004
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2015 - 04/2009
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2014 - 12/2010
3	AntigensIBA 07/2023 - 02/2002
3	RNA (Ribonucleic Acid)IBA 01/2023 - 04/2009
3	CarcinogensIBA 01/2020 - 12/2004
3	Volatile Organic CompoundsIBA 01/2019 - 07/2008
3	InflammasomesIBA 01/2018 - 08/2013
3	Phosphotransferases (Kinase)IBA 01/2018 - 11/2011
3	Monoclonal AntibodiesIBA 09/2016 - 07/2012
3	Pemetrexed (MTA)FDA Link 05/2015 - 04/2004
3	Peptides (Polypeptides)IBA 09/2013 - 04/2007
3	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2011 - 02/2002
2	AntioxidantsIBA 11/2023 - 05/2015
2	GlutaminaseIBA 11/2023 - 11/2017
2	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2023
2	16S Ribosomal RNAIBA 10/2022 - 01/2019
2	UbiquitinIBA 01/2022 - 08/2010
2	Oncogene Proteins (Oncogene Protein)IBA 12/2019 - 11/2017
2	Mitogen-Activated Protein Kinase 7IBA 01/2018 - 04/2013
2	Polysaccharides (Glycans)IBA 01/2018 - 01/2011
2	N 30IBA 01/2018 - 01/2008
2	Genetic Markers (Genetic Marker)IBA 11/2017 - 02/2005
2	CAM 5.2 antigenIBA 01/2017 - 09/2016
2	Keratins (Keratin)IBA 01/2017 - 02/2004
2	Calbindin 2IBA 01/2017 - 09/2016
2	AntibodiesIBA 03/2016 - 01/2011
2	ErbB Receptors (EGF Receptor)IBA 01/2016 - 11/2011
2	VaccinesIBA 10/2015 - 02/2002
2	Aldehyde DehydrogenaseIBA 05/2015 - 01/2014
2	NucleotidesIBA 05/2015 - 09/2012
2	Glucose (Dextrose)FDA LinkGeneric 05/2015 - 02/2002
2	Conditioned Culture MediaIBA 01/2015 - 06/2010
2	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 10/2014 - 11/2009
2	CopperIBA 01/2014 - 08/2008
2	Blood Proteins (Serum Proteins)IBA 01/2014 - 12/2010
2	VimentinIBA 01/2014 - 01/2014
2	integrin-linked kinaseIBA 05/2013 - 08/2011
2	AgarIBA 04/2013 - 04/2009
2	LuciferasesIBA 10/2012 - 05/2011
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2012 - 08/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 07/2006
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2011 - 09/2011
2	MineralsIBA 08/2011 - 01/2007
2	Ribonucleases (Ribonuclease)IBA 05/2011 - 06/2008
2	ranpirnase (Pannon)IBA 05/2011 - 06/2008
2	SERPIN-B5 (maspin)IBA 04/2009 - 01/2006
1	Hematoxylin (Haematoxylon)IBA 09/2023

Therapy/Procedure

36	Therapeutics 10/2023 - 03/2003
8	Immunotherapy 11/2023 - 10/2012
8	Radiotherapy 01/2022 - 12/2007
8	Drug Therapy (Chemotherapy) 11/2018 - 02/2006
5	Pneumonectomy (Lung Volume Reduction) 01/2018 - 03/2003
2	Neoadjuvant Therapy 01/2023 - 07/2008
2	Operative Surgical Procedures 01/2019 - 06/2014
2	Adjuvant Chemotherapy 09/2017 - 12/2007
2	Injections 01/2014 - 07/2011